141 related articles for article (PubMed ID: 2967702)
1. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
[TBL] [Abstract][Full Text] [Related]
2. Interaction of permanently charged analogs of dopamine with the D-2 dopaminergic receptor.
Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
Biochem Pharmacol; 1987 Nov; 36(22):3903-10. PubMed ID: 2961340
[TBL] [Abstract][Full Text] [Related]
3. Effect of permanently charged and uncharged dopaminergic agonists on the potassium-induced release of [3H]acetylcholine from striatal slices.
Sabol B; Boldry R; Farooqui T; Chang YA; Miller D; Uretsky N
Biochem Pharmacol; 1987 May; 36(10):1679-85. PubMed ID: 3109428
[TBL] [Abstract][Full Text] [Related]
4. Interaction of permanently charged chlorpromazine and dopamine analogs with the striatal D-1 dopaminergic receptor.
Wallace RA; Wallace L; Harrold M; Miller D; Uretsky NJ
Biochem Pharmacol; 1989 Jun; 38(12):2019-25. PubMed ID: 2525907
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and D2 dopaminergic activity of pyrrolidinium, tetrahydrothiophenium, and tetrahydrothiophene analogues of sulpiride.
Harrold MW; Wallace RA; Farooqui T; Wallace LJ; Uretsky N; Miller DD
J Med Chem; 1989 Apr; 32(4):874-80. PubMed ID: 2522993
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: indications for a common signal transduction pathway.
Drukarch B; Schepens E; Stoof JC
Neuroscience; 1990; 37(1):1-9. PubMed ID: 1978737
[TBL] [Abstract][Full Text] [Related]
7. Effect of a sulfonium analog of dopamine on the depolarization-induced release of [3H]acetylcholine from mouse striatal slices.
Turowski B; Szkrybalo M; Anderson K; Miller D; Uretsky N
Biochem Pharmacol; 1984 Aug; 33(15):2371-6. PubMed ID: 6466358
[TBL] [Abstract][Full Text] [Related]
8. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+.
Drukarch B; Schepens E; Schoffelmeer AN; Stoof JC
J Neurochem; 1989 Jun; 52(6):1680-5. PubMed ID: 2566646
[TBL] [Abstract][Full Text] [Related]
10. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
Forloni G; Bidzinski A; Fusi R; Ladinsky H; Consolo S
Life Sci; 1987 Oct; 41(14):1717-23. PubMed ID: 2958667
[TBL] [Abstract][Full Text] [Related]
11. Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release.
Gorell JM; Czarnecki B; Hubbell S
Life Sci; 1986 Jun; 38(24):2247-54. PubMed ID: 2940433
[TBL] [Abstract][Full Text] [Related]
12. Sustained activation does not desensitize the dopamine D2 receptor-mediated control of evoked in vitro release of radiolabeled acetylcholine from rat striatum.
Drukarch B; Schepens E; Stoof JC
Eur J Pharmacol; 1991 Apr; 196(2):209-12. PubMed ID: 1678719
[TBL] [Abstract][Full Text] [Related]
13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
14. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
Onali P; Olianas MC; Gessa GL
Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
[TBL] [Abstract][Full Text] [Related]
15. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptors labelled by [3H]quinpirole.
Seeman P; Schaus JM
Eur J Pharmacol; 1991 Oct; 203(1):105-9. PubMed ID: 1686763
[TBL] [Abstract][Full Text] [Related]
17. Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain.
Levant B; Grigoriadis DE; DeSouza EB
J Pharmacol Exp Ther; 1992 Sep; 262(3):929-35. PubMed ID: 1356154
[TBL] [Abstract][Full Text] [Related]
18. Interaction of AZA analogs of chlorpromazine with the dopamine D2 receptor.
Farooqui T; Markovich K; Wallace L; Miller D; Uretsky N
Gen Pharmacol; 1993 Jan; 24(1):147-51. PubMed ID: 8482489
[TBL] [Abstract][Full Text] [Related]
19. Differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation between the striatal complex of reptiles and the neostriatum of rats.
Henselmans JM; Hoogland PV; Stoof JC
Brain Res; 1991 Dec; 566(1-2):8-12. PubMed ID: 1687666
[TBL] [Abstract][Full Text] [Related]
20. The effect of intrastriatal application of directly and indirectly acting dopamine agonists and antagonists on the in vivo release of acetylcholine measured by brain microdialysis. The importance of the post-surgery interval.
De Boer P; Damsma G; Schram Q; Stoof JC; Zaagsma J; Westerink BH
Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):144-52. PubMed ID: 1349159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
